Clinical Trial Update: Autologous Platelet-Rich Plasma Therapy in the Treatment of Pyoderma Gangrenosum [NA]

View source ↗

Summary

A clinical trial evaluating autologous platelet-rich plasma therapy for Pyoderma Gangrenosum has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pyoderma Gangrenosum

Drugs mentioned

• Autologous platelet-rich plasma therapy (platelet-rich plasma)

Snippet

Sponsor: Ohio State University | Conditions: Pyoderma Gangrenosum | NA | Status: WITHDRAWN